Tag: Basal cell carcinoma

In clinical trials for locally advanced basal cell carcinoma (laBCC), the targeted therapy Odomzo (sonidegib) demonstrated an objective response rate of 56% for patients receiving the 200 mg daily dose. Approved by the FDA, **what is Odomzo** and how does this medication work to treat certain types of skin cancer?

Clinical trial data from studies like ERIVANCE show that muscle spasms affect a significant majority of patients, making it the most frequently reported answer to **what is the most common side effect of vismodegib**. Beyond muscle issues, the Hedgehog pathway inhibitor is also commonly associated with hair loss, taste disturbances, fatigue, and weight loss.

According to results from the ERIVANCE trial, a phase II clinical study, weight loss occurred in as many as 45% of patients treated with vismodegib for advanced basal cell carcinoma. This common side effect is often linked to other adverse reactions that impact nutritional intake during treatment.

Vismodegib is a targeted therapy used to treat certain types of basal cell carcinoma, with studies showing a significant reduction in the number of lesions in many patients. To ensure safety and effectiveness, it is critical to know precisely how to take vismodegib according to your doctor's instructions.

With a prevalence that can reach over 14% in individuals 80 years or older, actinic keratosis is a common condition treated by imiquimod [1.6.4]. This guide details how to apply imiquimod topical cream for effective and safe treatment of prescribed skin conditions.

Using Aldara (imiquimod) more frequently than prescribed, such as every day, significantly increases the risk of severe local skin reactions and systemic side effects. This topical medication, an immune response modifier, is not meant for daily application for most conditions, and altering the prescribed regimen can lead to an exaggerated inflammatory response.

In clinical studies, the objective response rate for patients with locally advanced basal cell carcinoma (laBCC) taking ODOMZO was 58%. To ensure maximum effectiveness and minimize side effects, it is crucial to understand the proper administration schedule, including when to take ODOMZO relative to meals and what to do for a missed dose.

Vismodegib, a targeted therapy for advanced basal cell carcinoma (BCC), is typically prescribed as an oral capsule taken once daily. Patients need to understand the specific instructions on **how is vismodegib given** to ensure safe and effective treatment. This article provides general information regarding its oral administration and important precautions.

Approved by the FDA for the treatment of specific skin conditions, imiquimod is a topical immune response modifier that triggers the body's own defense mechanisms. This article explains exactly how does imiquad work at the cellular level to combat viral infections and certain cancerous cells, leading to localized lesion clearance.

Approximately 58 million Americans develop actinic keratoses (AKs) annually, a condition Efudix Cream is commonly prescribed to treat. Efudix, a brand name for the topical chemotherapy agent fluorouracil, is primarily used to treat various precancerous and cancerous skin conditions caused by sun exposure.